Association of TREX1, MLPH, and CEP350 methylation with multiple Aurora kinase inhibitors is notable, as Aurora kinase inhibitors were highly effective against SCLC cell lines and induced a partial response in SCLC patients in a clinical study [24, 57]. Here, CEP350 is linked to small cell lung carcinoma.